Detalhe da pesquisa
1.
Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps. A workshop Report.
Biologicals
; 78: 17-26, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35840492
2.
Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities.
Expert Opin Drug Deliv
; 20(3): 315-322, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36649573
3.
Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) product.
J Control Release
; 361: 236-245, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37437849
4.
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges.
Front Public Health
; 10: 809675, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35309224
5.
Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.
Mol Ther
; 16(1): 52-9, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17998900
6.
Inclusion of the viral anti-apoptotic molecule M11L in DNA vaccine vectors enhances HIV Env-specific T cell-mediated immunity.
Virology
; 375(1): 48-58, 2008 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-18291435
7.
A simple macroscopic model for the diffusion and adsorption kinetics of r-adenovirus.
Biotechnol Bioeng
; 98(1): 239-51, 2007 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17597100
8.
Myxoma virus expressing human interleukin-12 does not induce myxomatosis in European rabbits.
J Virol
; 81(22): 12704-8, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17728229
9.
Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells.
J Neurovirol
; 13(6): 549-60, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18097886
10.
Poxvirus cancer therapy.
Recent Pat Antiinfect Drug Discov
; 1(3): 309-21, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18221156
11.
Current Status for High Titre Poxvirus Stock Preparation in CEF Under Serum-Free Medium Conditions: Implication for Vaccine Development.
Cytotechnology
; 48(1-3): 79-88, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19003034